Xingyu Zhu

Jinan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Unveiling tumor senescence-driven prognostic heterogeneity via MALISS in stage II/III colorectal cancer.

Unveiling tumor senescence-driven prognostic heterogeneity via MALISS in stage II/III colorectal cancer.

Journal: Frontiers in immunology

Published: November 12, 2025

The inspiration of methyltransferase in RNA methylation modification for targeted therapy of malignant tumors.

The inspiration of methyltransferase in RNA methylation modification for targeted therapy of malignant tumors.

Journal: Frontiers in immunology

Published: July 10, 2025

RBM15 Enhances 5-Fluorouracil Drug Sensitivity and Suppresses Gastric Cancer Progression by Modulating N6-Methyladenosine Modification of ECT2-Dependent IGF2BP3.

RBM15 Enhances 5-Fluorouracil Drug Sensitivity and Suppresses Gastric Cancer Progression by Modulating N6-Methyladenosine Modification of ECT2-Dependent IGF2BP3.

Journal: Research (Washington, D.C.)

Published: June 09, 2025

Molecular characteristics and cancer immunity of LRP1B and its relationship with the Hedgehog signaling pathway in colorectal cancer.

Molecular characteristics and cancer immunity of LRP1B and its relationship with the Hedgehog signaling pathway in colorectal cancer.

Journal: Frontiers in immunology

Published: January 26, 2025

MALMPS: A Machine Learning-Based Metabolic Gene Prognostic Signature for Stratifying Clinical Outcomes and Molecular Heterogeneity in Stage II/III Colorectal Cancer.

MALMPS: A Machine Learning-Based Metabolic Gene Prognostic Signature for Stratifying Clinical Outcomes and Molecular Heterogeneity in Stage II/III Colorectal Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: January 21, 2025

ESRP1 exerts anti-tumor role by promoting ferroptosis in diffuse-type gastric cancer.

ESRP1 exerts anti-tumor role by promoting ferroptosis in diffuse-type gastric cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: January 14, 2025

Clinical and molecular implications of cGAS/STING signaling in checkpoint inhibitor immunotherapy.

Clinical and molecular implications of cGAS/STING signaling in checkpoint inhibitor immunotherapy.

Journal: Frontiers in molecular biosciences

Published: January 07, 2025

Mechanism and Therapeutic Progress of One-Carbon Metabolic Key Enzyme: Serine Hydroxymethyltransferase 2 in Cancer.

Mechanism and Therapeutic Progress of One-Carbon Metabolic Key Enzyme: Serine Hydroxymethyltransferase 2 in Cancer.

Journal: Clinical Medicine Insights. Oncology

Published: November 22, 2024

Mechanisms and therapeutic potential of the hedgehog signaling pathway in cancer.

Mechanisms and therapeutic potential of the hedgehog signaling pathway in cancer.

Journal: Cell death discovery

Published: October 31, 2024

ZC3H13 mediates N6-methyladenosine modification of SNTB1 to promote epithelial-mesenchymal transition in gastric cancer.

ZC3H13 mediates N6-methyladenosine modification of SNTB1 to promote epithelial-mesenchymal transition in gastric cancer.

Journal: Cell death & disease

Published: October 05, 2024

Editorial: Tumor microenvironment and metabolic reprogramming in cancer.

Editorial: Tumor microenvironment and metabolic reprogramming in cancer.

Journal: Frontiers in immunology

Published: September 18, 2024

Clinical features and molecular landscape of cuproptosis signature-related molecular subtype in gastric cancer.

Clinical features and molecular landscape of cuproptosis signature-related molecular subtype in gastric cancer.

Journal: iMeta

Published: January 24, 2024

Showing 1-12 of 20

Last Updated: 09/26/2026